These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7048680)

  • 1. [Treatment of obesity in general practice with femoxetine. A controlled clinical trial of the effects of femoxetine and placebo].
    Kristensen JS; Christiansen P; Skrumsager BK
    Ugeskr Laeger; 1982 Mar; 144(13):939-42. PubMed ID: 7048680
    [No Abstract]   [Full Text] [Related]  

  • 2. Femoxetine in the treatment of obese patients in general practice. A randomized group comparative study with placebo.
    Bitsch M; Skrumsager BK
    Int J Obes; 1987; 11(2):183-90. PubMed ID: 3301710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind comparison of efficacy, safety, and side effects of Bionamin, phentermine compound, and placebo in the treatment of exogenous obesity.
    Cohen A; De Felice EA; Leb SM; Fuentes JG; Rothwell KG; Truant AP
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):323-34. PubMed ID: 4969672
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic trial of an anorectic agent using the double blind cross-over technic].
    Bienert HR; Uberla K
    Arzneimittelforschung; 1967 Mar; 17(3):336-42. PubMed ID: 4869817
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of obesity using appetite depressants].
    Ikeda Y
    Nihon Naika Gakkai Zasshi; 1995 Aug; 84(8):1290-4. PubMed ID: 7594950
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary clinical evaluation of a new appetite suppressant. A double-blind study.
    Feldman HS
    J Med Soc N J; 1966 Oct; 63(10):454-7. PubMed ID: 5341753
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind comparison of placebo and 42-548, a new appetite suppressant, in obese volunteers.
    De Felice EA; Bronstein S; Cohen A
    Curr Ther Res Clin Exp; 1969 May; 11(5):256-62. PubMed ID: 4977396
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fenfluramine. Anorexigenic drug in obstetrical practice].
    Ramírez Soto E; Delgado Urdapilleta J
    Ginecol Obstet Mex; 1969 Apr; 25(150):425-32. PubMed ID: 5814199
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month treatment of obesity with sibutramine 15 mg; a double-blind, placebo-controlled monocenter clinical trial in a Hispanic population.
    Cuellar GE; Ruiz AM; Monsalve MC; Berber A
    Obes Res; 2000 Jan; 8(1):71-82. PubMed ID: 10678261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind trial of anorectic agents.
    Bell DS
    Med J Aust; 1969 Mar; 1(11):599-600. PubMed ID: 4889482
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinically controlled trial of Perphoxene].
    Barbey JD
    Schweiz Rundsch Med Prax; 1971 Sep; 60(37):1242-6. PubMed ID: 4937701
    [No Abstract]   [Full Text] [Related]  

  • 13. Weight reduction with phenmetrazine and chlorphentermine a double-blind study.
    Hadler AJ
    Curr Ther Res Clin Exp; 1967 Nov; 9(11):563-9. PubMed ID: 4965505
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical experimentation with fenproporex in the treatment of obesity. Apropos of 40 cases].
    Warembourg H; Jaillard J
    Lille Med; 1968 Mar; 13(3):Suppl:273-6. PubMed ID: 4927185
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind clinical trial of an appetite depressant, fenfluramine, in general practice.
    Brodbin P; O'Connor CA
    Practitioner; 1967 May; 198(187):707-10. PubMed ID: 4860039
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study].
    González Barranco J; Rull JA; Lozano Castañeda O
    Prensa Med Mex; 1974; 39(5-6):298-9. PubMed ID: 4612507
    [No Abstract]   [Full Text] [Related]  

  • 18. Sibutramine in pregnancy.
    Ramzi F; Elias D; Mona S; Zreik TG
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):243-4. PubMed ID: 16219525
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical trial of fenfluramine.
    Traherne JB
    Practitioner; 1965 Nov; 195(169):677-80. PubMed ID: 5321366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.